CX3CR1 and Alzheimer disease: In a triple transgenic (3xTg: PS1M146V knock-in, transgenic APPSwe and tauP301L) model of Alzheimer’s disease (AD) it was shown that loss of Cx3cr1 resulted in the increase of microglial migration and prevented neuronal loss while levels of Aβ deposition remained unaltered [7].